Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Descovy 25 off patent uk?Loss of exclusivity viokace?Which non statins replicate lipitor's liver actions?Is lyrica bad for your liver?Descovy patent launch date?
See the DrugPatentWatch profile for bempedoic
Bempedoic acid is patented by Esperion Therapeutics, the company that developed the drug and holds key drug and formulation patent rights.
Bempedoic acid is the active ingredient in the cholesterol-lowering medicines sold under brands such as Nexletol (bempedoic acid) and Nexlizet (bempedoic acid plus ezetimibe).
For a searchable, up-to-date view of bempedoic acid patents and assignees (including Esperion Therapeutics), see DrugPatentWatch: https://www.drugpatentwatch.com/p/bempedoic-acid
Other Questions About Bempedoic :